ARCHIVES

CAP Issues Active Surveillance Guidance For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

Shingleton Nominated To President’s Panel

June 10, 1977

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Korn Revamps NCAB Committees, Names New Chairmen

October 5, 1984